Earnings per Common Share

6 Months Ended

Jun. 30, 2019

The following table sets forth the computation of basic and diluted earnings per common share (in millions, except per share amounts):



	Three Months Ended June 30,						Six Months Ended June 30,
	2019			2018			2019			2018
Basic:
Numerator:
Income from continuing operations	$	111.0		$	113.0		$	236.7		$	218.7
Less: Net income attributable to noncontrolling interests included in continuing operations	(19.7		)	(21.4		)	(42.6		)	(42.8		)
Less: Income allocated to participating securities	(0.3		)	(0.3		)	(0.7		)	(0.6		)
Income from continuing operations attributable to Encompass Health common shareholders	91.0			91.3			193.4			175.3
(Loss) income from discontinued operations, net of tax, attributable to Encompass Health common shareholders	(0.1		)	0.2			(0.6		)	(0.3		)
Net income attributable to Encompass Health common shareholders	$	90.9		$	91.5		$	192.8		$	175.0
Denominator:
Basic weighted average common shares outstanding	98.0			97.9			98.2			97.9
Basic earnings per share attributable to Encompass Health common shareholders:
Continuing operations	$	0.93		$	0.93		$	1.97		$	1.79
Discontinued operations	—			—			(0.01		)	—
Net income	$	0.93		$	0.93		$	1.96		$	1.79

Diluted:
Numerator:
Income from continuing operations	$	111.0		$	113.0		$	236.7		$	218.7
Less: Net income attributable to noncontrolling interests included in continuing operations	(19.7		)	(21.4		)	(42.6		)	(42.8		)
Income from continuing operations attributable to Encompass Health common shareholders	91.3			91.6			194.1			175.9
(Loss) income from discontinued operations, net of tax, attributable to Encompass Health common shareholders	(0.1		)	0.2			(0.6		)	(0.3		)
Net income attributable to Encompass Health common shareholders	$	91.2		$	91.8		$	193.5		$	175.6
Denominator:
Diluted weighted average common shares outstanding	99.3			99.6			99.5			99.6
Diluted earnings per share attributable to Encompass Health common shareholders:
Continuing operations	$	0.92		$	0.92		$	1.95		$	1.76
Discontinued operations	—			—			(0.01		)	—
Net income	$	0.92		$	0.92		$	1.94		$	1.76

The following table sets forth the reconciliation between basic weighted average common shares outstanding and diluted weighted average common shares outstanding (in millions):



	Three Months Ended June 30,		Six Months Ended June 30,
	2019	2018	2019	2018
Basic weighted average common shares outstanding	98.0	97.9	98.2	97.9
Restricted stock awards, dilutive stock options, and restricted stock units	1.3	1.7	1.3	1.7
Diluted weighted average common shares outstanding	99.3	99.6	99.5	99.6

In October 2018, February 2019, and May 2019, our board of directors declared cash dividends of $0.27 per share that were paid in January 2019, April 2019, and July 2019, respectively. On July 23, 2019, our board of directors approved an increase in our quarterly dividend and declared a cash dividend of $0.28 per share, payable on October 15, 2019 to stockholders of record on October 1, 2019. As of June 30, 2019 and December 31, 2018, accrued common stock dividends of $27.8 million and $28.4 million, respectively, were included in Accrued expenses and other current liabilities in our condensed consolidated balance sheets. Future dividend payments are subject to declaration by our board of directors.

See Note 16, Earnings per Common Share, to the consolidated financial statements accompanying the 2018 Form 10‑K for additional information related to our common stock.